Carta al editor “Colestasis intrahepática por Treponema pallidum en paciente inmunocompetente”

Orozco-Sebá BE, Viasus D, Meléndez E, Fuentes J, Tovar J, Amado EA, et al. Colestasis intrahepática por Treponema pallidum en paciente inmunocompetente. Biomedica.

;43:164-70.

University of Oxford. A phase-I dose-escalation study to evaluate the safety and immunogenicity of prime-boost immunizations with candidate HCV vaccines, ChAd3-

hliNSMut and MVA-hliNSMut in healthy volunteers and patients previously chronically infected with HCV [Internet]. Clinicaltrials.gov. 2023. Report No.: NCT03688061. Fecha de consulta: 31 de diciembre de 2022. Disponible en: https://clinicaltrials.gov/study/NCT03688061

National Institute of Allergy and Infectious Diseases (NIAID). A staged phase I/II study, to assess safety, efficacy and immunogenicity of a new hepatitis C prophylactic vaccine based on sequential use of AdCh3NSmut1 and MVA-NSmut. Clinicaltrials.gov. 2019. Report No.: NCT01436357. Fecha de consulta: 31 de diciembre de 2022. Disponible en: https://clinicaltrials.gov/study/NCT01436357